IDO1 and relapsing-remitting multiple sclerosis: Not so long ago, decreased IDO-1 expression and KYN levels (but not TDO expression) were found in the peripheral blood monocytes (PBMC) of relapsing-remitting MS (RRMS) patients compared to healthy controls [23].